Associated Papers
HMGCR genetic variability in Parkinson's disease in a Spanish cohort: associations with lipid metabolism and early onset.
Díaz-Belloso R et al.
Journal of Neurology, 2025
Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis.
Zahn LA et al.
Frontiers in Pharmacology, 2025
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E et al.
Biochemical Genetics, 2022
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
Jerome RN et al.
Drug Safety, 2020
Coding-sequence variants are associated with blood lipid levels in 14,473 Chinese.
Lu X et al.
Human Molecular Genetics, 2016
Reproducible Analysis of Post-Translational Modifications in Proteomes--Application to Human Mutations.
Holehouse AS et al.
Plos One, 2015
26659599 (PubMed )
Supplement: pone.0144692.s002.xlsx › suppTable_2.txt
Structural and energetic analyses of SNPs in drug targets and implications for drug therapy.
Sun HY et al.
Journal of Chemical Information and Modeling, 2013
24304102 (PubMed )
Supplement: ci400457v_si_001.xls › Sheet1
Functional non-synonymous polymorphisms prediction methods: current approaches and future developments.
González-Castejón M et al.
Current Medicinal Chemistry, 2011
Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.
Burkhardt R et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
Pharmacogenetic study of statin therapy and cholesterol reduction.
Chasman DI et al.
Jama, 2004
Sequence diversity in genes of lipid metabolism.
Garcia CK et al.
Genome Research, 2001
Select a paper to view details